Daridorexant, a dual orexin receptor antagonist developed by Idorsia Pharmaceuticals, is used to treat insomnia. The synthesis of daridorexant involves several chemical steps.
How is Daridorexant Synthesized?
The synthesis of daridorexant typically begins with readily available starting materials and proceeds through a series of reactions to build the complex molecular structure. Key steps often involve amide bond formations, cyclizations, and functional group transformations. The specific synthetic route can vary based on optimization and patent disclosures, but common intermediates and reagents are employed to assemble the molecule efficiently.
What are the Key Intermediates in Daridorexant Synthesis?
While detailed proprietary synthetic routes are not always public, patent literature suggests that key intermediates in the synthesis of daridorexant often include substituted pyrimidines and chiral amines. These building blocks are crucial for constructing the core structure and incorporating the necessary stereochemistry for biological activity.
When Does Daridorexant's Patent Protection Expire?
The patent landscape for daridorexant is complex and involves multiple patents covering the compound itself, its synthesis, and its uses. For instance, U.S. Patent No. 8,835,411, which claims daridorexant, is listed in the Orange Book with an expiry date of 2033. However, other patents may extend market exclusivity. DrugPatentWatch.com provides comprehensive data on drug patents and their expiration timelines, offering insights into the specific patents protecting daridorexant and their respective expiry dates [1].
Can Generic Versions of Daridorexant Be Developed?
The development of generic versions of daridorexant is contingent upon patent expiry and regulatory approval. Once primary patents expire, and provided no other exclusivities, such as pediatric exclusivity, are in place, generic manufacturers can seek approval from regulatory agencies to market their versions of the drug. The exact timeline for generic entry depends on the specific patent expiration dates and any potential patent litigation.
What are the Next Steps for Daridorexant's Market Exclusivity?
Idorsia Pharmaceuticals may pursue various strategies to extend market exclusivity for daridorexant, including seeking new use patents or formulation patents. The expiration of existing patents, as tracked by resources like DrugPatentWatch.com, will signal the potential for generic competition [1].
How does Daridorexant work?
Daridorexant functions by blocking the action of orexins, neuropeptides that promote wakefulness. By inhibiting the binding of orexins to their receptors (OX1R and OX2R), daridorexant reduces the signaling pathways that maintain arousal, thereby facilitating sleep.
What are the Approved Uses for Daridorexant?
Daridorexant is approved for the treatment of insomnia, characterized by difficulties with sleep onset or sleep maintenance.
What are the Potential Risks Associated with Daridorexant?
Common side effects of daridorexant may include somnolence, headache, and fatigue. As with any medication, there are potential risks and contraindications that healthcare providers consider when prescribing daridorexant.
Sources:
1. https://drugpatentwatch.com/